Noncontraceptive Hormones and Rheumatoid Arthritis in Perimenopausal and Postmenopausal Women

JAMA: The Journal of the American Medical Association

Volumn 255, Issue 10, 1986, Pages 1299-1303

  Vandenbroucke, Jan P ^a,b,d   Witteman, Jacqueline C M ^b   Valkenburg, Hans A ^a   Boersma, Johannes W ^c   Cats, Arnold ^d   Festen, Johannes J M ^e   Hartman, Arend P ^c   Huber Bruning, Olga ^g   Rasker, Johannes J ^f   Weber, Jacobus ^c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c Department of Rheumatology Municipal Hospital ^*  (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Department of Rheumatology de Stadsmaten Hospital ^*  (United States)

^f Department of Rheumatology Ziekenzorg Hospital ^*  (United States)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CLINICAL ARTICLE; DRUG EFFICACY; DRUG THERAPY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; HUMAN; JOINT; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; POSTMENOPAUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; THERAPY;

ARTHRITIS, RHEUMATOID; EPIDEMIOLOGIC METHODS; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MENOPAUSE; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRES; STATISTICS;

EID: 84944284049     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1986.03370100093024     Document Type: Article

References (28)

1. Vandenbroucke JP: The pill and rheumatoid arthritis: Benefits for the future? Biomed Pharmacother 1984;38:379-381.
2. Wingrave SJ, Kay CR: Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Lancet 1978;18:569-571.
3. Royal College of General Practitioners: Oral Contraceptives and Health, interim report. London, Pitman Medical, 1974.
4. Linos A, Worthington JW, O'Fallon WM, et al.: The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence, and mortality. Am J Epidemiol 1980;111:87-98.
5. Vandenbroucke JP, Valkenburg HA, Boersma JW, et al.: Oral contraceptives and rheumatoid arthritis: Further evidence for a preventive effect. Lancet 1982;2:839-842.
6. Allebeck P, Ahlbom A, Ljungstrom K, et al.: Do oral contraceptives reduce the incidence of rheumatoid arthritis? Scand J Rheumatol 1984; 13:140-146.
7. Linos A, Worthington JW, O'Fallon WM, et al.: Case-control study of rheumatoid arthritis and prior use of oral contraceptives. Lancet 1983;1:1299-1300.
8. Vandenbroucke JP: Oral contraceptives and rheumatoid arthritis. Lancet 1983;2:228-229.
9. Kay CR, Wingrave SJ: Oral contraceptives and rheumatoid arthritis. Lancet 1983;1:1437.
10. Esdaile J, Horwitz R: Resolving contradictory results in epidemiologic studies of oral contraceptives and rheumatoid arthritis, abstracted. Arthritis Rheum, 1984 suppl, p 53.
11. Del Junco DJ, Annegers JF, Luthra HS, et al.: Do oral contraceptives prevent rheumatoid arthritis? JAMA 1985;254:1938-1941.
12. Ropes MW, Bennet GA, Cobb S, et al.: Proposed diagnostic criteria for rheumatoid arthritis. Ann Rheum Dis 1957;16:115-125.
13. Woolf B: On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-253.
14. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959;22:719-748.
15. Miettinen OS: Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103:226-235.
16. Schlesselman JJ: Case-Control Studies: Design, Conduct and Analysis. London, Oxford University Press, 1982.
17. Dixon WJ (ed): BMDP Statistical Software. Berkeley, University of California Press, 1981.
18. Mantel N: Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963; 58:690-700.
19. Liang MH, Stoker V, Larson M, et al.: Oestrogen use, menopausal status and relationship to rheumatoid arthritis, abstracted. Ann Rheum Dis 1984;43:115-116.
20. Abruzzo JL: Rheumatoid arthritis and mortality. Arthritis Rheum 1982;25:1020-1023.
21. Allebeck P, Ahlbom A, Allander E: Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on the death certificate. Scand J Rheumatol 1981;10:301-306.
22. Vandenbroucke JP, Hazevoet HM, Cats A: Survival and cause of death in rheumatoid arthritis: A 25-year prospective follow-up. J Rheumatol 1984;11:158-161.
23. Unger A, Kay A, Griffin AJ, et al.: Disease activity and pregnancy associated 2-glycoprotein in rheumatoid arthritis during pregnancy. Br Med J 1983;286:750-752.
24. Thomson AW, Horne CHW: Biological and clinical significance of pregnancy-associated alpha-2-glycoprotein (2-PAG): A review. Invest Cell Pathol 1980;3:295-309.
25. Østensten M, Husby G: Pregnancy and rheumatic disease. Klin Wochenschr 1984;62:981-995.
26. Lahita RG: Sex steroids and the rheumatic diseases. Arthritis Rheum 1985;28:121-126.
27. Grossman JC: Regulation of the immune system by sex steroids. Endocr Rev 1984;5:435-455.
28. Buyon JP, Korchak HM, Rutherford LE, et al.: Female hormones reduce neutrophil responsiveness in vitro. Arthritis Rheum 1984;27:626-630.